Northeast Pharmaceutical Group announces that its subsidiary's products have been added to the National Essential Medicines List (2026 Edition). This inclusion is expected to facilitate wider use in medical institutions and positively impact the company's long-term development. However, the market outlook for these drugs is uncertain, making the impact on current performance unpredictable.
Summary generated by AI · Always verify with source document
Northeast Pharmaceutical Group Co., Ltd. Announcement on the Inclusion of Subsidiary Products in the National Essential Medicines List (2026 Edition)
This announcement and all members of the board of directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.